BioVie Inc.

NASDAQ: BIVI · Real-Time Price · USD
1.67
0.01 (0.60%)
At close: Aug 15, 2025, 3:59 PM
1.66
-0.59%
After-hours: Aug 15, 2025, 06:32 PM EDT

BioVie Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
229.38K 266.84K 237.42K 229.38K
Gross Profit
-229K -267K -237K -229K
Operating Income
-32.18M -45.08M -27.25M -138.05M
Interest Income
1.14M 562.26K 44.08K 21.97K
Pretax Income
-32.12M -50.26M -26.08M -130.25M
Net Income
-32.12M -50.26M -26.08M -130.25M
Selling & General & Admin
8.85M 11.55M 9.77M 4.64M
Research & Development
23.1M 33.3M 17.26M 133.19M
Other Expenses
229.38K 229.38K 229.38K 229.38K
Operating Expenses
31.95M 45.08M 27.25M 138.05M
Interest Expense
2.89M 4.3M 2.16M 559.46K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
32.18M 45.08M 27.25M 138.05M
Income Tax Expense
n/a n/a n/a 559.46K
Shares Outstanding (Basic)
439.7K 324.8K 246K 124.03K
Shares Outstanding (Diluted)
451.85K 324.83K 246.63K 124.03K
EPS (Basic)
-73 -154.7 -105.8 -1.48K
EPS (Diluted)
-73 -154.7 -106 -1.48K
EBITDA
-31.95M -45.69M -26.98M -137.8M
EBIT
-32.18M -45.08M -27.25M -129.69M
Depreciation & Amortization
229.38K 229.38K 229.38K 229.38K